rediff.com
X   
REAL-TIME QUOTE
Enter Company or MF
e.g. Tata motors, Reliance MF, 500570

524816 NATCO Group (B)

Natco Pharma Ltd. LIVE on BSE (View NSE)   

Add to watchlist
 
826.75   -9.40   -1.12%
Volume 14,844
Prev close 836.15
Day's H/L (Rs.) 843.85 - 819.00
52wk H/L (Rs.) 877.00 - 390.00
Mkt Cap (Rs. Cr) 2,777.88
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

NATCOPHARM

Natco Pharma Ltd. LIVE on NSE (View BSE)   

Add to watchlist
 
830.00   -6.45   -0.77%
Volume 58,897
Prev close 836.45
Day's H/L (Rs.) 844.00 - 820.00
52wk H/L (Rs.) 878.00 - 422.05
Turnover (Rs. Lacs) 488.72
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Market Voices for Natco Pharma Ltd.  (See all 91 market voices)   

140 Characters
  Cancel
Expert Voices - 4 day(s) ago US Court denied Teva's request for Copaxone patent stay. It orders other cpmpanies to launch Copaxone. Positive for
#Natco-Pharma-Ltd
as it has planned to launch it earlier. (CNBC-TV18)
#market-view
Reply   |   Share
Ramesh - 4 days ago  .
Reply   |  Share
Shibu Dc - 04 Apr 2014 no chance
#Natco-Pharma-Ltd
Reply   |   Share

Realtime news for Natco Pharma Ltd. (See all 627 news)

25 April 2014, 13:12
SC Chief Justice denies Teva's Request for an Injunction Relating to Generic Copaxone® - 1 day(s) ago
Natco extends gains on US court ruling over generic Copaxone - 2 day(s) ago
Natco Pharma rallies after US Supreme Court justice denies stay on Copaxone - 3 day(s) ago
Top stocks: RIL, TCS,Rel Cap, Natco Pharma, Persistent Systems - 4 day(s) ago
Natco Pharma urges Indian patent office to deny Gilead's hepatitis C drug patent in India: Report - 11 Apr 2014

BSE Announcements from Natco Pharma Ltd. (See all)

Supreme Court Chief Justice denies Teva's Request for an Injunction Relating to Generic Copaxoney; Clears Legal Hurdle for Mylan and Natco to Launch the same at Market Formation - 4 day(s) ago
Shareholding Pattern for March 31, 2014 - 12 Apr 2014

Company details for Natco Pharma Ltd.

Report Card

PE Ratios
33.57
EPS (Rs.)
24.91
Sales (Rs. Cr)
174.23
Face Value (Rs.)
10
Net Profit
Margin (%)
 
13.71
Last Bonus
Last Dividend(%)
50
Return on
Average Equity
 
14.53

Research Centre

Results: Quarterly  |  Half Yearly  |  Annual
Statements: Balance Sheet  |  P&L  |  Cash Flow  More: Dividend  |  Bonus  |  Share Holding  |  Capital Structures  |  Ratios

Natco Pharma Ltd. performance snapshot

If you had invested Rs.  in Natco Pharma Ltd.,   ago

You would have  Rs. 000.00 

Add to portfolio

Compare Natco Pharma Ltd. with other stocks

Piramal Enterprises Ltd.
586.85
Apollo Hospitals Enterprise Ltd.
885.50
Show more companies
Piramal Enterprises Ltd.
586.85
Apollo Hospitals Enterprise Ltd.
885.50
Glenmark Pharmaceuticals Ltd.
574.50
GlaxoSmithKline Pharmaceuticals Ltd.
2,486.80
Divi's Laboratories Ltd.
1,358.55
Cipla Ltd.
397.35
Biocon Ltd.
488.90
Aurobindo Pharma Ltd.
549.60
Ranbaxy Laboratories Ltd.
464.90
Strides Arcolab Ltd.
460.40
Show less companies
Close
Add Natco Pharma Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Natco Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close